For research use only. We do not sell to patients.
Name | TAK-875 |
---|---|
Iupac Chemical Name | (S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid |
Synonyms | Fasiglifam; TAK 875; TAK875 |
Molecular Formula | C29H32O7S |
Molecular Weight | 524.63 |
Smile | CC1=C(C(=CC(=C1)OCCCS(=O)(=O)C)C)C1=CC(=CC=C1)COC1=CC2=C([C@@H](CO2)CC(=O)O)C=C1 |
InChiKey | BZCALJIHZVNMGJ-HSZRJFAPSA-N |
InChi | InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1 |
CAS Number | 1000413-72-8 (free base); 1374598-80-7 (0.5 H2O) |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid powder |
---|---|
Purity | 98% |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |